The Elongin complex stimulates the rate of transcription elongation by RNA polymerase II by suppressing the transient pausing of the polymerase at many sites along the DNA template. Elongin is composed of a transcriptionally active A subunit and two small regulatory B and C subunits, the latter binding stably to each other to form a binary complex that interacts with Elongin A and strongly induces its transcriptional activity. To further understand the role of Elongin A in transcriptional regulation by RNA polymerase II, we are attempting to identify Elongin A-related proteins. Here, we report on the molecular cloning, expression, and biochemical characterization of human Elongin A3, a novel transcription elongation factor that exhibits 49 and 81% identity to Elongin A and the recently identified Elongin A2, respectively. The mRNA of Elongin A3 is ubiquitously expressed, and the protein is localized to the nucleus of cells. Mechanistic studies have demonstrated that Elongin A3 possesses similar biochemical features to Elongin A2. Both stimulate the rate of transcription elongation by RNA polymerase II and are capable of forming a stable complex with Elongin BC. In contrast to Elongin A, however, their transcriptional activities are not activated by Elongin BC. Structure-function analyses using fusion proteins composed of Elongin A3 and Elongin A revealed that the COOH-terminal region of Elongin A is important for the activation by Elongin BC.The synthesis of messenger RNA in eukaryotes is a complex biochemical process controlled by the concerted action of a set of general transcription factors that regulate the activity of RNA polymerase II during the initiation and elongation stages of transcription. At least six general transcription initiation factors (TFIIA, TFIIB, TFIID, TFIIE, TFIIF, and TFIIH) 1 have been identified in eukaryotic cells and found to promote the selective binding of RNA polymerase II to promoters and to support a basal level of transcription (1). In addition to the general initiation factors, at least 16 elongation factors have been defined biochemically and found to increase the efficiency of transcription elongation by RNA polymerase II (2-5).Among the elongation factors, SII and P-TEFb prevent RNA polymerase II from prematurely arresting transcription. SII does this by promoting passage of the polymerase through a variety of transcriptional impediments, including DNA sequences that act as intrinsic arrest sites and DNA-bound proteins and drugs (6). P-TEFb catalyzes the conversion of early, termination-prone elongation complexes into productive elongation complexes (7). The rest of the elongation factors such as TFIIF (8), Elongin A (9), Elongin A2 (10), ELL (11), and the Cockayne syndrome group B protein (CSB) (12), act to increase the overall rate of RNA chain elongation by RNA polymerase II by decreasing the frequency and/or duration of transient pausing of the polymerase at sites along the DNA template.Elongin was initially identified as a heterotrimer composed of A, B, and C subunits...